Sterling Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Buy |
6,049
+2,639
| +77% | +$9.61K | ﹤0.01% | 1761 |
|
|
2025
Q1 | $6.55K | Sell |
3,410
-2,654
| -44% | -$5.1K | ﹤0.01% | 2026 |
|
|
2024
Q4 | $11.5K | Buy |
6,064
+5,445
| +880% | +$10.3K | ﹤0.01% | 2102 |
|
|
2024
Q3 | $817 | Buy |
+619
| New | +$817 | ﹤0.01% | 2644 |
|
|
2018
Q2 | – | Sell |
-32,425
| Closed | -$309K | – | 840 |
|
|
2018
Q1 | $309K | Buy |
+32,425
| New | +$309K | ﹤0.01% | 795 |
|
|
2017
Q4 | – | Sell |
-42,903
| Closed | -$844K | – | 876 |
|
|
2017
Q3 | $844K | Buy |
+42,903
| New | +$844K | 0.01% | 677 |
|